MIPSS70+ Version 2.0: Mutation and Karyotype-Enhanced International Prognostic Scoring System for Primary Myelofibrosis

J Clin Oncol. 2018 Jun 10;36(17):1769-1770. doi: 10.1200/JCO.2018.78.9867. Epub 2018 Apr 30.

Authors

Ayalew Tefferi¹, Paola Guglielmelli¹, Terra L Lasho¹, Naseema Gangat¹, Rhett P Ketterling¹, Animesh Pardanani¹, Alessandro M Vannucchi¹

Affiliation

¹ Ayalew Tefferi, Mayo Clinic, Rochester, MN; Paola Guglielmelli, University of Florence, Florence, Italy; Terra L. Lasho, Naseema Gangat, Rhett P. Ketterling, and Animesh Pardanani, Mayo Clinic, Rochester, MN; and Alessandro M. Vannucchi, University of Florence, Florence, Italy.

PMID: 29708808
DOI: 10.1200/JCO.2018.78.9867

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

DNA Mutational Analysis
Humans
Karyotype
Mutation
Primary Myelofibrosis / genetics*
Primary Myelofibrosis / pathology
Prognosis